The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Hanover Media Strategy Limited naming Lorraine Clifford-Lee .

Filed returns
17
match these filters
Matching filed returns per period 0 1 2 3 5 May–Aug 2020: 1 filed returns Sep–Dec 2020: 2 filed returns Jan–Apr 2021: 1 filed returns Jan–Apr 2022: 1 filed returns Sep–Dec 2022: 1 filed returns Jan–Apr 2023: 3 filed returns May–Aug 2023: 2 filed returns Sep–Dec 2023: 1 filed returns Jan–Apr 2024: 1 filed returns May–Aug 2025: 1 filed returns Sep–Dec 2025: 2 filed returns Jan–Apr 2026: 1 filed returns 2021 2022 2023 2024 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Jan–Apr 2026 Hanover Media Strategy Limited Transport The role of the car rental sector in supporting Ireland’s tourism economy, regional connectivity and airport operations, and issues facing the tourism and car rental sectors arising from the proposed EU Clean Corporate… (Public policy or programme) 21 On lobbying.ie
Sep–Dec 2025 Hanover Media Strategy Limited Transport The taxi supply shortage in Ireland and the need to increase licensed taxi driver and vehicle supply to support the urban, rural and night-time economies. (Public policy or programme) 14 On lobbying.ie
Sep–Dec 2025 Hanover Media Strategy Limited Health AV Room Briefing Event to discuss a Proposal for an Early Access Programme for Innovative Oncology Medicines (Public policy or programme) 41 On lobbying.ie
May–Aug 2025 Hanover Media Strategy Limited Transport Correspondence and meetings regarding the Taxi Supply Shortage (Public policy or programme) 5 On lobbying.ie
Jan–Apr 2024 Hanover Media Strategy Limited Health Invitation to a roundtable discussion on the challenges and pressures posed by influenza on the Irish health system, with a particular focus on the over 65s population. (Public policy or programme) 15 On lobbying.ie
Sep–Dec 2023 Hanover Media Strategy Limited Health Chronic kidney disease in Ireland: recommendations to improve health outcomes for chronic kidney disease patients and reduce healthcare costs. (Matters involving public funds) 15 On lobbying.ie
May–Aug 2023 Hanover Media Strategy Limited Health Discussion on the level of influenza vaccine protection for the over 65 population in Ireland. (Public policy or programme) 23 On lobbying.ie
May–Aug 2023 Hanover Media Strategy Limited Health Ireland's readiness for the rollout of radioligand therapy (Public policy or programme) 10 On lobbying.ie
Jan–Apr 2023 Hanover Media Strategy Limited Health The landscape for innovative and precision medicines in Ireland. (Public policy or programme) 12 On lobbying.ie
Jan–Apr 2023 Hanover Media Strategy Limited Health Ireland's readiness for the rollout of radioligand therapy (Public policy or programme) 12 On lobbying.ie
Jan–Apr 2023 Hanover Media Strategy Limited Health Rare Disease Policy (Legislation) 17 On lobbying.ie
Sep–Dec 2022 Hanover Media Strategy Limited Health Request for a meeting to discuss the landscape for innovative and precision medicines in Ireland. (Public policy or programme) 18 On lobbying.ie
Jan–Apr 2022 Hanover Media Strategy Limited Health Update on AstraZeneca sponsored roundtable outcomes held for Chronic Obstructive Pulmonary Disease (Public policy or programme) 14 On lobbying.ie
Jan–Apr 2021 Hanover Media Strategy Limited Health Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) 15 On lobbying.ie
Sep–Dec 2020 Hanover Media Strategy Limited Health Creation of national policy with regard to Orphan Medicinal Products (Public policy or programme) 5 On lobbying.ie
Sep–Dec 2020 Hanover Media Strategy Limited Health Briefed select parliamentarians on potential Covid-19 vaccine (Public policy or programme) 22 On lobbying.ie
May–Aug 2020 Hanover Media Strategy Limited Health Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) 16 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 14 82.4%
Transport 3 17.6%